跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44,015 条关于
“PhasED-Seq”
全部
44,015
临床试验
35,317
药物
871
机构
60
资讯
7,767
去年
Foresight Diagnostics and Roche Resolve Patent Dispute with PhasED-Seq Licensing Agreement for Non-Hodgkin's Lymphoma Diagnostics
9个月前
Foresight Diagnostics Showcases Ultrasensitive MRD Technology in Multiple Lymphoma Studies at ASH 2025
2年前
Novel Cell-Free DNA Assays Enhance MRD Detection in Lymphoma Subtypes
去年
ctDNA-Based MRD Testing Shows Superior Prognostic Value in DLBCL First-Line Treatment
去年
Allogene and Foresight Diagnostics Forge $37.3M Partnership for Lymphoma Diagnostic Development
去年
Ultrasensitive DNA Detection Shows Promise in B-Cell Lymphoma Remission Assessment
9个月前
Natera Acquires Foresight Diagnostics for $275 Million to Advance Molecular Residual Disease Detection
去年
PRECISE-HL Trial Launches to Reduce Chemotherapy in Hodgkin Lymphoma Using ctDNA Testing
去年
Allogene Therapeutics Advances AlloCAR T Pipeline in Oncology and Autoimmune Diseases
上个月
MaxCyte Launches CHANGE-seq-BE and ONE-seq-BE to Strengthen Off-Target Assessment for Base Editing Therapies
第 1 页,共 777 页
上一页
下一页